William F. Feely

4.9k total citations
29 papers, 567 citations indexed

About

William F. Feely is a scholar working on Oncology, Food Science and Molecular Biology. According to data from OpenAlex, William F. Feely has authored 29 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Food Science and 5 papers in Molecular Biology. Recurrent topics in William F. Feely's work include Cancer Immunotherapy and Biomarkers (9 papers), CAR-T cell therapy research (4 papers) and Pesticide and Herbicide Environmental Studies (3 papers). William F. Feely is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), CAR-T cell therapy research (4 papers) and Pesticide and Herbicide Environmental Studies (3 papers). William F. Feely collaborates with scholars based in United States, Spain and Germany. William F. Feely's co-authors include Louis S. Crouch, Peter G. Wislocki, Mario Sznol, Margaret K. Callahan, Jedd D. Wolchok, Alexander M. Lesokhin, Matthew M. Burke, Naiyer A. Rizvi, Harriet M. Kluger and Blessing Agunwamba and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Agricultural and Food Chemistry and Journal of Hepatology.

In The Last Decade

William F. Feely

28 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William F. Feely United States 14 277 171 95 70 65 29 567
Jutaro Tadano Japan 12 96 0.3× 78 0.5× 147 1.5× 48 0.7× 29 0.4× 41 490
George M. Szczech United States 16 44 0.2× 80 0.5× 159 1.7× 364 5.2× 12 0.2× 32 781
Yu Kuang China 16 48 0.2× 88 0.5× 243 2.6× 29 0.4× 43 0.7× 34 518
Philippe Gros Canada 8 115 0.4× 105 0.6× 210 2.2× 147 2.1× 27 0.4× 8 598
Chiara Lucchetti Italy 13 147 0.5× 73 0.4× 259 2.7× 11 0.2× 62 1.0× 20 540
Patricia Novelli United Kingdom 5 43 0.2× 48 0.3× 218 2.3× 31 0.4× 10 0.2× 6 656
T. Hashimoto Japan 11 41 0.1× 89 0.5× 210 2.2× 135 1.9× 6 0.1× 23 479
Laura Trejo‐Avila Mexico 12 62 0.2× 97 0.6× 187 2.0× 92 1.3× 7 0.1× 26 710
Peter Mayser Germany 17 51 0.2× 69 0.4× 91 1.0× 54 0.8× 4 0.1× 59 846

Countries citing papers authored by William F. Feely

Since Specialization
Citations

This map shows the geographic impact of William F. Feely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William F. Feely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William F. Feely more than expected).

Fields of papers citing papers by William F. Feely

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William F. Feely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William F. Feely. The network helps show where William F. Feely may publish in the future.

Co-authorship network of co-authors of William F. Feely

This figure shows the co-authorship network connecting the top 25 collaborators of William F. Feely. A scholar is included among the top collaborators of William F. Feely based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William F. Feely. William F. Feely is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Son, Ji Y., Emily Hinchcliff, Shuqi Wang, et al.. (2025). EON: Phase II trial of etigilimab (MPH313) in combination with nivolumab in patients with recurrent platinum-resistant clear cell ovarian cancer.. Journal of Clinical Oncology. 43(16_suppl). 5573–5573.
2.
McKean, Meredith, Ecaterina E. Dumbrava, Omid Hamid, et al.. (2023). 1021MO Safety and efficacy of etigilimab (anti-TIGIT) with nivolumab (anti-PD1) in recurrent/advanced solid tumors. Annals of Oncology. 34. S621–S622. 3 indexed citations
3.
4.
Callahan, Margaret K., Christine E. Horak, Michael A. Curran, et al.. (2013). Peripheral and tumor immune correlates in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab.. Journal of Clinical Oncology. 31(15_suppl). 3003–3003. 30 indexed citations
5.
Treitel, Michelle, Thomas Marbury, Richard A. Preston, et al.. (2012). Single-Dose Pharmacokinetics of Boceprevir in Subjects with Impaired Hepatic or Renal Function. Clinical Pharmacokinetics. 51(9). 619–628. 34 indexed citations
6.
Treitel, Michelle, Thomas Marbury, Richard A. Preston, et al.. (2012). Single-Dose Pharmacokinetics of Boceprevir in Subjects with Impaired Hepatic or Renal Function. Clinical Pharmacokinetics. 51(9). 619–628. 4 indexed citations
7.
Feely, William F., et al.. (2003). Determination and Confirmation of 5-Hydroxyflunixin in Raw Bovine Milk Using Liquid Chromatography Tandem Mass Spectrometry. Journal of Agricultural and Food Chemistry. 51(13). 3753–3759. 20 indexed citations
8.
Feely, William F., et al.. (2003). Determination of Flunixin in Edible Bovine Tissues Using Liquid Chromatography Coupled with Tandem Mass Spectrometry. Journal of Agricultural and Food Chemistry. 51(26). 7555–7559. 28 indexed citations
9.
Feely, William F., et al.. (2002). Flunixin Residues in Milk after Intravenous Treatment of Dairy Cattle with14C-Flunixin. Journal of Agricultural and Food Chemistry. 50(25). 7308–7313. 32 indexed citations
10.
Feely, William F. & Louis S. Crouch. (1997). Fate of [14C]Emamectin Benzoate in Cabbage. 2. Unextractable Residues. Journal of Agricultural and Food Chemistry. 45(7). 2758–2762. 3 indexed citations
11.
Crouch, Louis S., et al.. (1997). Fate of [14C/3H]Emamectin Benzoate in Cabbage. 1. Extractable Residues. Journal of Agricultural and Food Chemistry. 45(7). 2744–2757. 10 indexed citations
12.
Feely, William F., et al.. (1997). Incorporation of Emamectin Benzoate (MK-0244) Residues into Soluble Sugars of Plants. Journal of Agricultural and Food Chemistry. 45(10). 4131–4136. 4 indexed citations
13.
Feeney, William P., et al.. (1997). Dermal penetration of 4″-(epi-methylamino)-4″-deoxyavermectin B1a benzoate in the rhesus monkey. Food and Chemical Toxicology. 35(10-11). 1085–1089. 4 indexed citations
14.
Mushtaq, Mohammad, et al.. (1996). Immobility of Emamectin Benzoate in Soils. Journal of Agricultural and Food Chemistry. 44(3). 940–944. 24 indexed citations
15.
Crouch, Louis S. & William F. Feely. (1995). Fate of [14C]Emamectin Benzoate in Head Lettuce. Journal of Agricultural and Food Chemistry. 43(12). 3075–3087. 15 indexed citations
16.
Feely, William F., Louis S. Crouch, Byron H. Arison, et al.. (1992). Photodegradation of 4''-(epimethylamino)-4''-deoxyavermectin B1a thin films on glass. Journal of Agricultural and Food Chemistry. 40(4). 691–696. 23 indexed citations
17.
Feely, William F. & Peter G. Wislocki. (1991). Avermectin B1A in celery: acetone-unextractable residues. Journal of Agricultural and Food Chemistry. 39(5). 963–967. 4 indexed citations
18.
Crouch, Louis S., William F. Feely, Byron H. Arison, et al.. (1991). Photodegradation of avermectin B1a thin films on glass. Journal of Agricultural and Food Chemistry. 39(7). 1310–1319. 46 indexed citations
19.
Maynard, Michael S., et al.. (1989). Fate of the 8,9-Z isomer of avermectin B1a in rats. Journal of Agricultural and Food Chemistry. 37(6). 1487–1491. 5 indexed citations
20.
Wislocki, Peter G., William F. Feely, B. R. Bennett, et al.. (1988). Dermal penetration of avermectin B1a in the rhesus monkey. Toxicology and Applied Pharmacology. 94(2). 238–245. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jutaro Tadano Breakdown of academic impact, for papers by George M. Szczech Breakdown of academic impact, for papers by Yu Kuang Breakdown of academic impact, for papers by Philippe Gros Breakdown of academic impact, for papers by Chiara Lucchetti Breakdown of academic impact, for papers by Patricia Novelli Breakdown of academic impact, for papers by T. Hashimoto Breakdown of academic impact, for papers by Laura Trejo‐Avila Breakdown of academic impact, for papers by Peter Mayser
Rankless by CCL
2026